High plasma level of plasmin-α2-plasmin inhibitor complex is predictor of poor prognosis in patients with lung cancer

Clinica Chimica Acta

Volumn 244, Issue 1, 1996, Pages 69-81

  Taguchi, Osamu ^a   Gabazza, Esteban C ^a   Yoshida, Masamichi ^a   Yamakami, Tomoya ^a   Kobayashi, Hiroyasu ^a   Shima, Teruo ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Lung cancer; Plasmin 2 plasmin inhibitor complex; Prognosis; Thrombin antithrombin III complex

Indexed keywords

ANTIPLASMIN; ANTITHROMBIN III; PLASMIN; THROMBIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

EID: 0030058751     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(95)06196-7     Document Type: Article

References (25)

1. Sack GH, Levin J, Bell W. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasm. Medicine 1977;56:1-37.
2. Gabazza EC, Taguchi O, Yamakami T, Machishi M, Ibata H, Suzuki S. Evaluating the prethrombotic state in lung cancer using molecular markers. Chest 1993;103:196-200.
3. Gordon SG. Cancer cell procoagulants and their role in malignant disease. Semin Thromb Haemostasis 1992;18:424-433.
4. Gabazza EC, Taguchi O, Yamakami T et al. Coagulation-fibrinolysis system and markers of collagen metabolism in lung cancer. Cancer 1992;70:2631-2636.
5. Wojtukiewicz MZ, Zacharski LR, Moritz TE, Edwards RL, Rickles FR. Prognostic significance of blood coagulation tests in carcinoma of lung and colon. Blood Coag Fibrin 1992;3:429-437.
6. Mountain CF. A new international staging system for lung cancer. Chest 1986;89 (Suppl):225.
7. Pelzer H, Schwards A, Heimburger N. Determination of human thrombin-antithrombin III complex in plasma with enzyme-linked immunoassay. Thromb Haemostasis 1988; 50:101-106.
8. 2-plasmin inhibitor. Blood 1987;69:446-453.
9. Armitage P, Berry G. Statistical methods in medical research. Cambridge, MA: Blackwen Scientific Publications, 1994.
10. Cox DR. Regression models and life tables (with discussion). J R Stat Soc 1972;187: 187-220.
11. Constantini V, Zacharski LR. Fibrin and cancer. Thromb Haemostasis 1993;69: 406-414.
12. Kwaan HC, Keer HN. Fibrinolysis and cancer. Semin Thromb Haemostasis 1990;16: 230-235.
13. Zacharski LR, Henderson WG, Rickles FR et al. Effect of warfarin anticoagulation on survival in small cell carcinoma of the lung: VA Cooperative #75. J Am Med Assoc 1981;245:831-835.
14. Bauer KA and Rosenberg RD. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. Blood 1987;70:343-350.
15. Liotta LA. Tumor invasion and metastasis - role of the extracellular matrix. Cancer Res 1986;46:1-7.
16. Stetler-Stevenson WG, Liotta LA, and Kleiner DE Jr. Extracellular matrix 6: role of the matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 1993;7:1434-1441.
17. Gabazza EC, Taguchi O, Yoshida M et al. Neutrophil activation and collagen metabolism in lung cancer. Clin Chim Acta 1995;236:101-108.
18. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 1985;44: 139-266.
19. 1-like molecule by plasmin during co-culture. J Cell Biol 1989;109:309-315.
20. Blasi F, Vasalli JD, Dano K. Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J Cell Biol 1987;104:801-804.
21. Yamamura S, Modlin RL, Ohmen JD and Moy RL. Local expression of inflammatory cytokines in cancer. J Clin Invest 1993;91:1005-1010.
22. Zacharski LR, Wojtukiewicz MZ, Constantini V, Ornstein DL, Memoli VA. Pathways of coagulation/fibrinolysis activation in malignancy. Semin Thromb Hemostasis 1992; 18:104-116.
23. Ornstein DL, Zacharski LR, Memoli VA et al. Coexisting macrophage-associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissues. Cancer 1991;68:1061-1067.
24. Burtin P, Chavanel G, Andre-Bougaran J, Gentile A. The plasmin system in human adenocarcinomas and their metastases. A comparative immunofluorescence study. Int J Cancer 1987;39:170-178.
25. Zacharski LR, Memoli VA, Constantini V, Wojtukiewicz, Ornestein DL. Clotting factors in tumor tissue: implications for cancer therapy. Blood Coag Fibrin 1990;1: 71-78.